Modifications of scaffold II at C8, designed to occupy a solvent filled cavity between the catalytic center and Met163, Cys168 together with His267 of the neighboring subunit, proved highly significant (Table 2 ).
← all excerpts
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
1
—
—